- Germany's Asta Medica, a subsidiary of Degussa, has set up a new company in the Ukraine. From its Dresden headquarters, Asta Medica (see also page 26) has opened up in seven eastern European countries over the last two years, and a further company in Riga, Baltic Republic, is near completion. The firm hopes for a brisk development of the privately-financed pharmaceutical market in the Ukraine, which not only compares in surface size to Russia but also has a 52 million population (ie, similar to France). Initially, Asta Medica will offer for sale drugs to treat cardiovascular, cancer and respiratory diseases, but at a later stage will set up its own self-medication business.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze